Phase 2 Osteoarthritis Trial, Recruiting NCT06034262 Sponsor: TBF Genie Tissulaire Condition: Osteoarthritis
Back to Osteoarthritis

Phase 2 Osteoarthritis Trial, Recruiting

NCT06034262
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years, of any gender
  • People who have osteoarthritis causing symptoms in the middle joint of a finger (the proximal interphalangeal joint)
  • People who have been receiving medical treatment for functional symptoms for more than 3 months with no improvement, and whose doctor has determined that surgery is appropriate
  • People whose disability score on a specific hand function questionnaire (QuickDash) is above a certain threshold, indicating meaningful impact on daily life (confirm with trial site)
  • People who have pain of 4 or more out of 10 at rest in the affected finger joint
  • People who have been given information about the study and have agreed to take part
  • People who are covered by a national health insurance plan

Who may not be able to join:

  • Women who are pregnant, breastfeeding, or not using effective contraception
  • People who have nerve-related conditions causing functional problems such as abnormal sensitivity to touch
  • People who have epilepsy that is not well controlled, or a nerve condition that means a certain type of local anaesthetic cannot safely be used
  • People who are in custody or detained by a court or government order
  • People who are under a legal protection order or who are unable to give their own consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 4 72 68 69 09

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
TBF Genie Tissulaire
Registry
ClinicalTrials.gov
Start date
7 October 2024
Est. completion
1 January 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in the symptomatology related to the PIPJ OA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov